cyclohexanol has been researched along with Hyperactivity, Motor in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Miguel, R; De Petrocellis, L; Di Marzo, V; Fernández-Ruiz, J; Lastres-Becker, I; Makriyannis, A | 1 |
| Anghelescu, I; Luborzewski, A; Regen, F; Schindler, F | 1 |
| Braida, D; Pozzi, M; Sala, M | 1 |
| Hayase, T; Yamamoto, K; Yamamoto, Y | 1 |
| Brocco, M; Dekeyne, A; Girardon, S; Millan, MJ; Veiga, S | 1 |
5 other study(ies) available for cyclohexanol and Hyperactivity, Motor
| Article | Year |
|---|---|
Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids, Neutral; Animals; Arachidonic Acids; Basal Ganglia; Cannabinoid Receptor Modulators; Capsaicin; Corpus Striatum; Cyclohexanols; Disease Models, Animal; Dopamine; Endocannabinoids; gamma-Aminobutyric Acid; Huntington Disease; Hyperkinesis; Male; Motor Activity; Nitro Compounds; Palmitates; Piperidines; Propionates; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2003 |
Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder.
Topics: Aged; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperkinesis; Modafinil; Neurologic Examination; Venlafaxine Hydrochloride | 2006 |
CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils.
Topics: Analgesics; Animals; Brain; Brain Ischemia; Cyclohexanols; Electroencephalography; Gerbillinae; Hyperkinesis; Male; Neuroprotective Agents; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2000 |
Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cocaine; Cyclohexanols; Drug Interactions; Drug Therapy, Combination; Endocannabinoids; Hyperkinesis; Ligands; Mice; Mice, Inbred ICR; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Seizures | 2001 |
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Ataxia; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Environment; Hyperkinesis; Mice; Motor Activity; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |